Definium Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Definium Therapeutics, Inc. (DFTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value of $86.13 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $86.13M.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $18.69B.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $8.75B.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $5.46B.
USD
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2026-06-30 | $86.13M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $18.69B 10-Q · filed 2026-05-07 |
| 2025-12-31 | $8.75B 10-K · filed 2026-02-26 |
| 2025-09-30 | $5.46B 10-Q · filed 2025-11-06 |
| 2025-06-30 | $1.04B 10-Q · filed 2025-07-31 |
| 2025-03-31 | $805.67M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.50B 10-K · filed 2025-03-06 |
| 2024-09-30 | $633.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.39B 10-Q · filed 2024-08-13 |
| 2024-03-31 | $2.33B 10-Q · filed 2024-05-08 |
| 2022-03-31 | $4.43M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $5.10M 10-K · filed 2022-03-28 |
CAD
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value |
|---|---|
| 2023-12-31 | 11.97M CAD 10-K · filed 2024-02-28 |
| 2023-09-30 | 1.45M CAD 10-Q · filed 2023-11-02 |
| 2023-06-30 | 4.40M CAD 10-Q · filed 2023-08-03 |
| 2023-03-31 | 4.00M CAD 10-Q · filed 2023-05-04 |
| 2022-12-31 | 2.67M CAD 10-K · filed 2023-03-09 |
| 2022-09-30 | 4.48M CAD 10-Q · filed 2022-11-10 |
| 2022-06-30 | 2.09B CAD 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |